Insitu Announces Successful Demonstration of Integrator Unmanned Aircraft System at IDEX 2015

Insitu announced today the successful demonstration of its Integrator unmanned aircraft system during the live flight event at IDEX in Abu Dhabi. The two-day live fly took place on 24 and 25 February at the Al Tareef Airstrip, and was held in conjunction with the Unmanned Systems Exhibition and Conference (UMEX).

Insitu Integrator UAS Launches at IDEX Live Fly Event

Integrator performed two flights, showcasing key features and capabilities including ease of transport and set up, small footprint launch and recovery systems and its open-architecture ground control application, ICOMC2.

"Our mission is to provide our global customers with the power to make the best decisions," said Suzanne McNamara, Insitu's vice president of business development. "Integrator delivers the endurance and payload flexibility our customers need to save lives, protect assets and successfully complete their mission. We are extremely honored to have the opportunity to demonstrate our tactical multi-INT platform to IDEX visitors."

Insitu's Integrator is a robust aircraft built on more than 10 years of operational experience. The system is modular, flexible and multi-mission capable, with six payload spaces and 40 lbs. of payload capacity. The USMC Program of Record RQ-21A Blackjack (under NAVAIR PMA-263) is a variant of this platform.

Show attendees are invited to learn more about the capabilities of the Integrator platform as well as Insitu's other unmanned technologies at the Insitu booth (02-A42 in the US Pavilion).

Source: http://www.insitu.com/

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.